Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

EVOLUT LOW RISK Trial

123 views

Published on

La Dra. Regina Dalmau desgrana en #SECenACC19 los resultados del EVOLUT LOW RISK Trial presentado en Nueva Orleans.

Published in: Science
  • Be the first to comment

  • Be the first to like this

EVOLUT LOW RISK Trial

  1. 1. Evolut Low Risk Trial Regina Dalmau DOI: 10.1056/NEJMoa1816885
  2. 2. Evolut Low Risk Trial Regina Dalmau Objective: To asses the safety and efficacy of TAVR with the EVOLUTE self expanding supra-annular valve compared with SAVR in patients with low predicted risk of 30-day surgical mortality.
  3. 3. Evolut Low Risk Trial Regina Dalmau
  4. 4. Evolut Low Risk Trial Regina Dalmau STS <3%
  5. 5. Evolut Low Risk Trial Regina Dalmau
  6. 6. Evolut Low Risk Trial Regina Dalmau
  7. 7. Evolut Low Risk Trial Regina Dalmau
  8. 8. Evolute Low Risk Trial Regina Dalmau
  9. 9. Evolut Low Risk Trial Regina Dalmau
  10. 10. Evolut Low Risk Trial Regina Dalmau
  11. 11. Evolut Low Risk Trial Regina Dalmau
  12. 12. Evolut Low Risk Trial Regina Dalmau
  13. 13. Evolute Low Risk Trial Regina Dalmau • ¿Son comparables SAPIEN 3 y EVOLUTE? • ¿Se consolidarán los resultados con un seguimiento más largo? • ¿Necesitamos hacer estudios head to head? • ¿A quién no poner una TAVI? ¿Low risk a cualquier edad?

×